Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
about
Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration.Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy.Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.The metastasis-inducing protein AGR2 is O-glycosylated upon secretion from mammary epithelial cells.PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarkerAGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture.A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signalingN-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling.
P2860
Q35672234-807B788B-7032-4E3E-9EC9-972220D64963Q35742477-A711C230-1B0F-4AAF-A237-73E9234D4AFBQ35748982-962A4533-76D7-43DC-8174-8646FCDD4CCFQ35794952-62C44261-2775-4C46-8330-4D5B687EC090Q35799421-943666BF-888A-4FBC-8523-6EAEA22F2492Q36469793-B844518F-D070-4AD4-AE37-12F20319EB4DQ36621607-10A8A664-FC3E-478E-810D-101045293CD7Q36896806-D1265D38-1C9F-4222-A186-EA18A3ED66F4Q36903188-6D21AB87-5A21-4A38-B40C-D2081B9D92B9Q37685245-86B0A9AE-47C5-4AC7-B36D-6B1FFF235629Q38748082-2FD7F9F4-5480-4F76-BC1D-810FF40825FBQ38986420-427975AE-FCAB-48F0-83E3-29392DD439DCQ39062377-E773FCD0-A111-4C4F-A618-40DD36D0F092Q41412520-93921C9D-2B8F-45BB-A1AD-24617BCC71CDQ42658326-7BC703EC-4907-4F34-8471-76E81384F6AC
P2860
Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@en
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@nl
type
label
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@en
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@nl
prefLabel
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@en
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Anterior gradient 2 and 3--two ...... gens in prostate cancer cells.
@en
P2093
Andrea Wunderlich
Andrew C B Cato
Bernd Timmermann
Erald Shehu
Helmut Klocker
Martin Kerick
Michal R Schweiger
P2860
P304
P356
10.1111/FEBS.12118
P407
P577
2013-02-13T00:00:00Z